# ImPROving Quality of LIFe in the Long COVID Patient

> **NCT05823896** · PHASE2 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 219 (actual)

## Conditions studied

- Post-COVID-19 Syndrome
- Long COVID
- Long Covid19
- COVID-19
- POTS - Postural Orthostatic Tachycardia Syndrome
- Post COVID-19 Condition
- Post-COVID Syndrome
- Post COVID-19 Condition, Unspecified
- Postinfectious Inflammation
- Postinfectious Disorder

## Interventions

- **DRUG:** Nirmatrelvir/ritonavir
- **DRUG:** Placebo/ritonavir

## Key facts

- **NCT ID:** NCT05823896
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-11-28
- **Final completion:** 2024-11-28
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823896, "ImPROving Quality of LIFe in the Long COVID Patient". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05823896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*